Sunshine Biopharma (SBFM) Research & Development (2011 - 2026)
Sunshine Biopharma (SBFM) recorded Research & Development of $13,222 in Q2 2026, down 93.3% from $196,232 a year earlier and down 58.3% from the prior quarter.
Powered by 
Analysis
Sunshine Biopharma (SBFM) Research & Development (2011 - 2026) Analysis & Trends
On a TTM basis, Sunshine Biopharma's Research & Development came in at $237,745 as of Jun 30, 2026, down 65.4% year-over-year; for FY2025, it came in at $604,308, down 35.3% from FY2024.
- Annual Research & Development has a five-year compound annual growth rate of 222.7% (FY2020 to FY2025).
- Across earlier years, Research & Development came in at $933,902 in FY2024 (-49.7%), $1.86 million in FY2023 (+128.6%), $811,858 in FY2022 (+20.8%) and $672,209 in FY2021.
- The Q2 2026 figure is the lowest quarterly Research & Development since Q4 2020.
- On a year-over-year basis, Research & Development has declined for eight consecutive quarters, with an average decline of 52.7% over the last eight quarters.
- Peak year-over-year performance for Research & Development in the last five years was growth of 702.2% in Q2 2023, against a decline of 93.3% in Q2 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at $31,724 (Q1 2026), $73,501 (Q4 2025) and $119,298 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 993.80 Mn |
| 10 | Sunshine Biopharma | 1.12 Mn | -37.97 Mn | 2.43 Mn | 13,222.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 13,222.00 |
| Mar 31, 2026 | 31,724.00 |
| Dec 31, 2025 | 73,501.00 |
| Sep 30, 2025 | 119,298.00 |
| Jun 30, 2025 | 196,232.00 |
| Mar 31, 2025 | 215,277.00 |
| Dec 31, 2024 | 149,272.00 |
| Sep 30, 2024 | 126,362.00 |
| Jun 30, 2024 | 436,235.00 |
| Mar 31, 2024 | 222,033.00 |
| Dec 31, 2023 | 816,328.00 |
| Sep 30, 2023 | 238,012.00 |
| Jun 30, 2023 | 368,565.00 |
| Mar 31, 2023 | 432,925.00 |
| Dec 31, 2022 | 41,763.00 |
| Sep 30, 2022 | 362,500.00 |
| Jun 30, 2022 | 45,943.00 |
| Mar 31, 2022 | 361,652.00 |
| Dec 31, 2021 | 91,198.00 |
| Sep 30, 2021 | 222,465.00 |
API Access
Sunshine Biopharma Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=SBFM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "SBFM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=SBFM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();